Published online Jan 16, 2023. doi: 10.12998/wjcc.v11.i2.479
Peer-review started: September 22, 2022
First decision: November 5, 2022
Revised: November 16, 2022
Accepted: January 3, 2023
Article in press: January 3, 2023
Published online: January 16, 2023
Processing time: 111 Days and 19.8 Hours
Hypertriglyceridemia is a well-recognized etiology of acute pancreatitis, and the incidence of hypertriglyceridemic acute pancreatitis (HTG-AP) has increased in frequency worldwide in response to lifestyle changes. It is crucial to identify hypertriglyceridemia as the cause of pancreatitis and initiate appropriate treatment. Insulin treatment produces effective lowering of triglycerides, but in our opinion, non-diabetic patients with HTG-AP require separate consideration to avoid hypoglycemia.
Core Tip: This is a comment on an article concerning the incidence and clinical characteristics of hypertriglyceridemic acute pancreatitis (HTG-AP). We believe that the risk of hypoglycemia must be considered and described for non-diabetic patients with HTG-AP receiving insulin infusion to decrease serum triglyceride level.